HMOX1 and teratoma: This selective elimination of pluripotent cells was validated in vivo. hES cells pre-treated with 10 μg/mL STB-HO were incapable of forming teratomas upon xenotransplantation (0/15 animals), a statistically significant contrast to the 100% teratoma formation (10/10 animals) in controls.